聯瑞新材(688300.SH)業績快報:上半年淨利9222.63萬元,同比增長16.54%
格隆匯8月14日丨聯瑞新材(688300.SH)披露2022年半年度業績快報,報吿期內,公司實現營業收入3.51億元,同比增長21.32%;利潤總額1.05億元,同比增長16.27%;歸屬於母公司所有者的淨利潤9222.63萬元,同比增長16.54%;報吿期末總資產13.82億元,較期初增長5.90%;歸屬於母公司的所有者權益11.34億元,較期初增長3.69%。
報吿期內,面對國內外疫情、能源價格上漲等不利經營環境,公司積極採取應對措施,化解不利因素,保障了經營業績持續增長。公司大力拓展海外市場,持續獲得海外知名客户認可,市場佔有率逐步提高,高端產品保持增長態勢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.